Clinical Trial Update: Tirzepatide in Idiopathic Intracranial Hypertension Trial [Phase 4]

View source ↗

Summary

Duke University is conducting a Phase 4 trial of tirzepatide for idiopathic intracranial hypertension, with enrollment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Intracranial Hypertension

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

Sponsor: Duke University | Conditions: Idiopathic Intracranial Hypertension (IIH) | Phase 4 | Status: NOT_YET_RECRUITING